病毒性乙型肝炎是一种严重危害人民健康的疾病。此病发病率高,危害性强,部分病人还转为慢性肝病,继而发展成肝硬化,而且与肝癌的发生有密切的关系,是一种严重的社会公害。目前对乙型肝炎尚无特效的治疗药物,因此对该病的予防措施就更为重要。 乙型肝炎疫苗是予防乙型肝炎的特效制剂。自1982年问世以来,已在美、法、日本、荷兰、南朝鲜等国家相继试制成功并投产。我国亦小量试制成功,并证明疫苗是安全可靠的。 Viral hepatitis B is a disease that seriously affects people’s health. The high incidence of the disease, endangering, some patients also turned to chronic liver disease, and then developed into cirrhosis, but also with the occurrence of liver cancer are closely related, is a serious social hazard. Currently there is no effective treatment for hepatitis B, so precautionary measures for the disease are even more important. Hepatitis B vaccine is an effective anti-hepatitis B preparation. Since its publication in 1982, it has been successfully piloted and put into production in the United States, France, Japan, the Netherlands, and South Korea. Our country also trial-produced a small amount, and proved that the vaccine is safe and reliable.